What is the CJC no DAC / Ipamorelin blend?
This preparation contains two separate synthetic peptides co-lyophilized in one vial: 5mg of CJC-1295 without DAC, also written as modified GRF (1-29), and 5mg of Ipamorelin. Both are standard reference sequences in growth hormone secretagogue receptor and growth hormone releasing factor receptor research, which is why they are commonly handled in the same experimental series. The peptides are not conjugated and are quantified separately.
What is in the vial
CJC-1295 without DAC is a 29 residue analog of the 1-29 fragment of growth hormone releasing factor, carrying substitutions that improve resistance to enzymatic cleavage, with a molecular weight of approximately 3367.9 Da. The DAC in the name refers to the drug affinity complex moiety used on the longer acting analog, which is absent here. The two are separate substances and are frequently confused: CJC-1295 with DAC is a 30 residue molecule of approximately 3647.25 Da under CAS 446262-90-4, while the material in this vial is the 29 residue form under CAS 863288-34-0. Ipamorelin is a synthetic pentapeptide, Aib-His-D-2-Nal-D-Phe-Lys-NH2, molecular weight approximately 711.85 Da, notable for containing non-natural residues, which makes its mass signature distinctive under LC-MS.
Where this material appears in the literature
Both sequences appear in receptor pharmacology literature as reference ligands, and in analytical work on peptide stability and detection. Iron Rack Labs supplies the blend for laboratory investigation of that kind and makes no claim about what either peptide does in any living subject.
Related material in the catalogue
This blend is held under peptide blends, alongside the BPC-157 / TB-500 preparation. Tesamorelin, a longer GRF analog, is held separately under long chain peptides.
Analysis and certification
Every lot is analyzed by an independent laboratory before release, using RP-HPLC for purity and LC-MS for identity confirmation. The certificate of analysis is published against the lot number rather than against the product page, so the document you read is the document for the vial you receive. The lot number printed on the vial label is the link between the two.
Purity specification
Lots are released against a ≥98% purity specification, determined by RP-HPLC peak area. A specification is a release threshold, not a description of every lot. The measured figure for the lot you receive is stated on its certificate of analysis and may sit above the specification.
Where a measured figure and the specification differ, the certificate is the record that applies to your material. Analytical figures relate to the lot they are published against and carry no implication of suitability for any purpose beyond laboratory research.
Research use only
Iron Rack Labs supplies this material as a reference standard for laboratory research. It is not supplied for any use in humans or animals, it is not a drug, dietary supplement, food or cosmetic, and nothing on this page describes or implies any such use. Sale is restricted to persons aged 18 or over who are qualified researchers or who purchase on behalf of a research institution, laboratory or business.
| Compound |
CJC-1295 without DAC and Ipamorelin co-lyophilized blend |
| Class |
Two synthetic peptides in one vial |
| Component 1 |
CJC-1295 no DAC, also known as modified GRF (1-29), 29 amino acids, approximately 3367.9 Da, CAS 863288-34-0 |
| Component 2 |
Ipamorelin, 5 amino acids, Aib-His-D-2-Nal-D-Phe-Lys-NH2, approximately 711.85 Da, CAS 170851-70-4 |
| Labeled quantity |
5mg CJC-1295 no DAC and 5mg Ipamorelin per vial, 10mg total peptide |
| Appearance |
White to off white lyophilized powder |
| Purity specification |
≥98% per component |
| Purity method |
RP-HPLC, each component integrated separately |
| Identity method |
LC-MS, both components confirmed |
| Solubility |
Soluble in sterile water and aqueous buffers for analytical preparation |
| Content verification |
Both components are reported on the certificate for the lot |
Characterization. Values above describe the compound as supplied. The figures for the lot you receive, including measured purity, are stated on its certificate of analysis.
How this material is tested
Two separate analyses are carried out on every lot before release, and both appear on the certificate.
- RP-HPLC, for purity. Reversed phase high performance liquid chromatography separates the material by hydrophobicity. The main peak is integrated against total peak area, and that ratio is the purity figure reported on the certificate.
- LC-MS, for identity. Liquid chromatography coupled to mass spectrometry confirms that the mass of the main peak matches the expected mass for the compound, which is what distinguishes the correct sequence from a closely related one.
A complete certificate carries the compound name, the lot number, the test date, the method, the measured purity and the name of the laboratory. If any of those is missing, or the lot number on the vial does not match the certificate, contact us before using the material.
Storing the CJC no DAC / Ipamorelin blend
Lyophilized material is shipped cold and should be moved into freezer storage on arrival. Store the sealed vial dry at −20°C or below, protected from light and moisture. Returned promptly to those conditions, the dry solid is the most stable form this material takes.
Preparing stock solutions
Prepare stock solutions in sterile water or an appropriate aqueous buffer at a concentration suited to your assay, expressed in mg/mL. Allow the vial to reach room temperature before opening, add solvent down the vial wall rather than directly onto the solid, and let the material dissolve without vigorous agitation. Calculate concentrations for both components from the labeled quantities, since co-lyophilized peptides cannot be separated after reconstitution.
Solutions are less stable than the lyophilized solid. Prepare close to the point of use, hold at 2 to 8°C for short periods only, and aliquot before freezing so that repeated freeze and thaw cycles are avoided.
On arrival
Check that the vial is intact and sealed, that the compound name and labeled quantity match your order, and that the lot number on the label matches the certificate published for it. If anything does not match, or the packaging has clearly failed in transit, contact us before using the material. Problems visible on arrival should be reported within 7 days so that a carrier claim remains possible.
Handling and disposal
Assess the hazards of this material before handling it and use appropriate controls and protective equipment. It has not been characterized toxicologically and should be treated as potentially hazardous. Anyone handling it should be trained for the work.
Dispose of unused material, vials and packaging lawfully and in line with your institution's waste procedures.
Record keeping
Record the lot number in your notes at the point of first use, alongside the date the vial was opened and the concentration of any stock prepared. Certificates are published against the lot number rather than the product, so the lot number is the only reliable link between your results and the analytical data for the material that produced them. If a question arises about a result months later, that link is what keeps the work auditable.